Trials / Completed
CompletedNCT01202123
Post Marketing Surveillance of MENOPUR
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,501 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of highly purified (HP) menotrophine to Korean women.
Conditions
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2013-11-01
- Completion
- 2014-02-01
- First posted
- 2010-09-15
- Last updated
- 2014-02-21
Locations
19 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01202123. Inclusion in this directory is not an endorsement.